Add BrightSurf on Google Email

A herbal compound to fight autoimmunity

A team from Osaka University discovered that celastrol blocks the progression of rheumatoid arthritis by inhibiting a protein complex that promotes autoimmune responses. The researchers found that celestrol binds to COMMD3 covalently, preventing the formation of the COMMD3/8 complex and impairing antibody production.

SourceOsaka University·JournalScience Immunology·TypeExperimental study·DateApr 4, 2023

Researchers announce findings from landmark clinical trial for pediatric Crohn’s disease

Researchers from the University of North Carolina Health Care announce that patients receiving anti-TNF biologic treatments combined with methotrexate had better outcomes than those treated with adalimumab alone. The study, published in Gastroenterology, provides clear results that can immediately impact patient care.

SourceUniversity of North Carolina Health Care·JournalGASTROENTEROLOGY·TypeRandomized controlled/clinical trial·DateApr 3, 2023

Pulsed radiofrequency with steroid injection brings sciatica relief

A new study published in Radiology found that a minimally invasive procedure combining pulsed radiofrequency and epidural steroid injection treatment leads to better pain reduction and disability improvement. The results showed significant benefits at four, 12, and 52 weeks compared to steroid injections alone.

SourceRadiological Society of North America·JournalRadiology·TypeRandomized controlled/clinical trial·DateMar 28, 2023

LSU Health New Orleans pain protocol eliminates need for opioids following knee replacement in most patients

A novel surgical pain management strategy has been developed to reduce opioid use after total knee arthroplasty. The study found that changing prescriptions for opioids at discharge from automatic to upon request dramatically decreased opioid use, with over half of patients recovering without opioid use.

SourceLouisiana State University Health Sciences Center·JournalJournal of Experimental Orthopaedics·TypeExperimental study·DateFeb 27, 2023

Maintaining healthy lifestyle might prevent up to 60% of inflammatory bowel disease cases

A large international study found that adopting and maintaining a healthy lifestyle may prevent up to 60% of Crohn's disease and ulcerative colitis cases. The study analyzed data from over 300,000 participants and estimated that a low risk score for inflammatory bowel disease could have prevented a significant proportion of cases if an...

SourceBMJ Group·JournalGut·TypeObservational study·DateDec 6, 2022

A new nanoparticle to act at the heart of cells

Researchers have developed a transport nanoparticle to deliver an anti-inflammatory drug, Necrosulfonamide (NSA), directly into macrophages to combat inflammatory overactivation. The mesoporous silica nanoparticle is fully biodegradable and non-toxic, showing remarkable efficacy in reducing inflammation.

SourceUniversité de Genève·JournalJournal of Controlled Release·TypeNews article·DateNov 8, 2022

Study identifies potential target for treating childhood blood cancer

Researchers have pinpointed a possible new target for treating patients with juvenile myelomonocytic leukemia (JMML), a highly aggressive blood cancer. Treatment using anti-inflammatories showed promise in rescuing JMML-like symptoms in zebrafish, suggesting a potential new approach to combating the disease.

SourceeLife·JournaleLife·TypeExperimental study·DateMay 10, 2022

Do pain relievers impede bone drug’s efficacy?

Researchers found that NSAID use negates the bone-protective effects of bisphosphonate clodronate on preventing osteoporotic fractures. The study suggests caution in extrapolating these data to more widely used bisphosphonates, as concomitant usage may lead to reduced fracture risk.

SourceWiley·JournalJournal of Bone and Mineral Research·DateApr 20, 2022

Southampton-led study shows need for painkiller caution to prevent kidney damage

A recent study led by Dr Simon Fraser from the University of Southampton found that painkiller prescriptions decreased during the pandemic, but high-risk individuals continued to receive them. The research highlights the need for greater caution when prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to prevent kidney damage.

SourceUniversity of Southampton·JournalBJGP Open·TypeMeta-analysis·DateFeb 17, 2022

Killing pain without hurting the body: Novel compound that is potentially safer than current drugs

Researchers discover novel compound AD732 with anti-inflammatory and analgesic properties, outperforming standard NSAIDs while causing minimal harm. The compound may be a safer alternative for treating pain and inflammation in difficult diseases like ulcerative colitis and Crohn's disease.

SourceRitsumeikan University·JournalEuropean Journal of Pharmaceutical Sciences·TypeExperimental study·DateDec 14, 2021

New advice on arthritis drugs

Researchers found that combining anti-rheumatic drugs can reduce the risk of cardiovascular disease in rheumatoid arthritis patients. Two specific combinations - tumour necrosis factor inhibitors and hydroxychloroquine - showed promise in preserving endothelial function.

SourceFlinders University·JournalFrontiers in Cardiovascular Medicine·DateJul 5, 2021

Which medications are most toxic to the liver?

A recent study analyzing 156,570 hospitalized patients found that anti-infective agents, cancer medications, and nonsteroidal anti-inflammatory drugs were the most toxic to the liver. Voriconazole, an antifungal medication, was associated with the highest incidence of drug-induced liver injury.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateMay 5, 2021

Short-term exposure to air pollution may impede cognition; Aspirin could help

A new study found that short-term air pollution exposure can impair cognitive performance, but taking nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin can reduce these effects. The study used data from the Normative Aging Study and found that elevated PM2.5 exposure over 28 days was associated with declines in global cognitiv...

Biologists from RUDN University suggested a new substance to suppress neuroinflammation

Researchers found that hymecromone, a spasmolytic drug, reduces the production of anti-inflammatory molecules in astrocytes. This could lead to new treatments for neurodegenerative diseases such as Alzheimer's. Hymecromone's mechanism of action is thought to involve reducing hyaluronic acid synthesis, which affects inflammation.

SourceRUDN University·JournalInternational Journal of Molecular Sciences·DateFeb 26, 2021

Toward safer steroids: Scientists devise method for improving safety of drug used to treat COVID-19, autoimmune disorders and more

Researchers at Scripps Research Institute devised a method to separate beneficial anti-inflammatory properties from unwanted side effects in glucocorticoid drugs. Two new compounds show steroidal anti-inflammatory action with specific traits, including boosting muscle supply and reducing risk of muscle-wasting.

SourceScripps Research Institute·JournalNature Chemical Biology·DateFeb 2, 2021

Two anti-inflammatory drugs found that inhibit the replication of the COVID-19 virus

Researchers have identified two anti-inflammatory drugs that can inhibit the replication of the COVID-19 virus. The study used computational techniques to analyze 6,466 authorized drugs and predicted that Carprofen and Celecoxib could be effective in inhibiting the main protease enzyme responsible for the virus's replication.

SourceUniversitat Rovira i Virgili·JournalInternational Journal of Molecular Sciences·DateMay 27, 2020

Cardiovascular impairment in COVID-19

Researchers recommend using cardiovascular anti-inflammatory therapies to treat COVID-19 patients with severe cardiovascular problems, citing potential risks with current treatments. The study provides guidance for clinicians on selecting specific therapies depending on disease severity and patient response.

SourceFrontiers·JournalFrontiers in Cardiovascular Medicine·DateApr 30, 2020

Immunology: Tonsils as a testbed

A team of scientists at Ludwig-Maximilians-Universität München has isolated immune cells from human tonsils obtained following routine surgery, allowing them to analyze the immune response and test anti-inflammatory agents. The new culture system enables researchers to study human lymphoid tissue under physiologically relevant conditions.